The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments

Machado-Vieira, Rodrigo, Baumann, Jacqueline, Wheeler-Castillo, Cristina, Latov, David, Henter, Ioline D., Salvadore, Giacomo, Zarate, Carlos A.·2010·Pharmaceuticals
DOI 10.3390/ph3010019

Cited by (263)

Items 201–263 of 263

  1. Aberrant topology of the default mode network is associated with phosphatidylcholine and triglyceride levels in major depressive disorder
    Yizhou Ma, Xin-Yu Wang, Wen-Liang Wang, Jing Zhang, Xiao-Hong Liu, LI Du-xing, Zhen-He Zhou, Limin Chen, Hongliang Zhou · 2026 · World Journal of Psychiatry
  2. A unifying theory of brain signaling and its possible role in acquired chronic disease
    Gerard Pereira, Michael Corbett, Suzanne D. Vernon, Shaun Colburn, Sanjay Chanda · 2026 · Frontiers in Neuroscience
  3. Effect of iTBS on suicidal ideation and emotion regulation in major depressive disorder: a randomized clinical trial
    Pu Li, Yan Wang, Zhengzhi Deng, Jiang Wu, Zhihong Chen, Rui Fu, Dezhong Yao, Shu Yu, Guojian Yan, Hongmei Yan · 2026 · BMC Psychiatry
  4. Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim test
    Lenka Seillier, Alexandre Seillier, Morgan A. Zvolska, Romana Šlamberová · 2026 · Journal of Psychopharmacology
  5. Revoking serotonin's auto license
    Tim Fulmer · 2010 · Science-Business eXchange
  6. Farmakoterapia depresji u pacjentów z zaawansowanymi chorobami
    Jakub Grabowski, Mateusz Przybylak · 2019 · Palliative Medicine in Practice
  7. Esketamina intranasal: un nuevo abordaje para el tratamiento de la depresión resistente al tratamiento
    Ana María González-Pinto · 2020 · Psiquiatría Biológica
  8. Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin
    Anthony Principe · 2022 · SURG Journal
  9. Computational Analysis of the Structure of the Kappa-Opioid Receptor for the Development of Selective Antagonists
    Caitlin E. Scott, Emily V. Pickering, Graham T. Anderson · 2022 · ACS symposium series
  10. ANTIDEPRESSANT EFFECT OF ETHANOLIC EXTRACT OF MIMOSA PUDICA COMPARED WITH IMIPRAMINE IN MICE MODELS
    FLOYD VERNON D’SOUZA, Michelle Jayaraj, HALMOND MELROYD DSOUZA · 2022 · Asian Journal of Pharmaceutical and Clinical Research
  11. Brain stimulation for treatment-resistant depression
    Aluisio Rodrigues, Lisiane Martins, Nivaldo Ribeiro Villela, Laís Boralli Razza, André R. Brunoni · 2023 · Progress in brain research
  12. Efficacy and acceptability of next step treatment strategies in adults with treatment-resistant major depressive disorder: protocol for systematic review and network meta-analysis
    Jan Jacobus Muit, Philip van Eijndhoven, Andrea Cipriani, Iris Dalhuisen, Suzanne C. van Bronswijk, Toshi A. Furukawa, Henricus Gerardus Ruhé · 2022 · BMJ Open
  13. Mood Disorders With Psychotic Features: Diagnostic Considerations and Treatment Challenges
    Nidal J. Moukaddam, Jennifer Howse, Joel S. Kanter, Muhammad qasim Chaudhry, Katharine D. Wojcik · 2023 · Psychiatric Annals
  14. Neuron-Glia Signaling Regulates the Onset of the Antidepressant Response
    Vicky Yao, Ammar Aly, Salina Kalik, Jodi E. Gresack, Wei Wang, Annie Handler, Anne Schaefer, Olga G. Troyanskaya, Paul Greengard, Revathy U. Chottekalapanda · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression
    Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor, Jennifer S. Rabin, Mario Masellis, Amit Singnurkar, Christopher B. Pople et al. · 2023 · Research Square
  16. The more, the merrier? Establishing a dose-response relationship for the effects of cognitive control training on depressive symptomatology
    Yannick Vander Zwalmen, David Demeester, Kristof Hoorelbeke, Nick Verhaeghe, Chris Baeken, Ernst H. W. Koster · 2024
  17. Efeito da catuama® na sintomatologia da síndrome da ardência bucal: ensaio clínico, randomizado, duplo-cego, placebo-controlado
    Juliana Cassol Spanemberg · 2011 · Americanae (AECID Library)
  18. Effects of voluntary imipramine intake via food and water in paradigms of anxiety and depression in naïve mice
    P. Joao, Bakhmet Anastassia, Margarida Araújo-Correia, Barbosa Valença Andreia, Tatyana V. Strekalova, W. M. Steinbusch Harry · 2016 · Translational Neuroscience and Clinics
  19. Envolvimento do óxido nítrico na metilação do DNA induzida por estresse
    Izaque de Sousa Maciel · 2018
  20. The Search for Rapid Acting Antidepressants: Research Synthesis and Perspectives
    Gerard Sanacora, Brandon M. Kitay, Samuel T. Wilkinson · 2019 · Elsevier eBooks
  21. Ethical Issues in Neuropsychopharmacotherapy: US Perspective
    Michael J. Menconi, Veljko Dubljević · 2020 · Springer eBooks
  22. Immune-to-Brain Signaling Effects on the Neural Substrate for Reward: Behavioral Models of Aversion, Anhedonia, and Despair
    Anna M. Klawonn, Michael Fritz · 2020 · Neuromethods
  23. Contribution des jeunes neurones dans les neurotransmissions dans l’hippocampe après un traitement chronique avec la fluoxétine
    Julie Doan · 2020
  24. The impact of pharmacological manipulations of brain energy metabolism and glymphatic system on TrkB neurotrophin signalling
    Erika Niittymäki · 2021 · Työväentutkimus Vuosikirja
  25. Paris, Église Saint Roch (Ier arrt), Tombeau de Madame de La Live de Jully par Falconet (1753)
    Eugène Atget · 1927 · Appartient à un fonds de photographies vendu à l'Ecole des beaux-arts par Atget, seul photographe inscrit sous son nom dans les registres d'entrée des collections ; Numéro d'inventaire ENSBA : 38688
  26. P.0375 Treatment patterns and factors driving the decision to discharge patients with major depressive disorder hospitalized for suicidal ideation with intent
    Ute Lewitzka, Joana Anjo, Tiina Annus, Stephane Borentain, Kirsty Hope, Andrew Major, Marguerite O’Hara, Maurizio Pompili · 2021 · European Neuropsychopharmacology
  27. Effects of Voluntary Imipramine Intake via Food and Water in Paradigms of Anxiety and Depression in naïve Mice
    João Pedro Costa-Nunes, А.А. Bakhmet, Margarida Araújo-Correia, Andreia Barbosa Valença, Tatyana V. Strekalova, Harry W.M. Steinbusch · 2016 · Translational Neuroscience and Clinics
  28. Psychiatric Treatment Preferences for the Management of Postconcussion Symptoms
    Aaron Slone Jeckell, Lydia J. McKeithan, Aaron Michael Yengo-Kahn, Katherine A. Gifford · 2022 · Advances in Psychiatry and Behavioral Health
  29. Cannabis-Based Medicinal Products in the Management of Emotionally Unstable Personality Disorder (EUPD): A Narrative Review and Case Series
    Waseem Sultan, Anup Mathew, Matthew R. D. Brown, Juan Francisco Galvez-Florez, Guillermo Moreno‐Sanz · 2022 · Brain Sciences
  30. Delphi panel to obtain clinical consensus regarding the importance of rapid reduction in depressive symptoms in patients with major depressive disorder with acute suicidal ideation or behavior (MDSI)
    Stephane Borentain, Carter D. McCormick, Kruti Joshi, Marguerite O’Hara, Qiaoyi Zhang, Siobhán Mulhern-Haughey, Sarah Richards, Joana Anjo, David Zante, Rachel M. Kewley et al. · 2022 · Research Square
  31. Phenylketonuria with mental retardation and valproate-induced hyperammonemia
    Delia Sterpu · 2020 · Romanian Journal of Psychiatry & Psychotherapy
  32. The psychological impact of non-responsiveness to antidepressants on patients with depression and the role of pharmacogenomics-based drug therapy
    C. Agbo, U. Chima, C. Nwachuya, N. V. Enang, C. Okoye, Sylvia M. Mbaji, Ngozi M. Uzokwe, A. P. Ngige, O. Iwuchukwu, Andrea Okoloekwe · 2023 · American Journal of Pharmacotherapy and Pharmaceutical Sciences
  33. Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature
    Justina A. Warnick, Rachel I. Gifeisman, Kaustubh Pravin Joshi, Sophie A. Roe, Rick A. Hiciano, Christopher P. Conroy, Sohrab Zahedi · 2024 · Journal of Correctional Health Care
  34. Prolonged blockade of NMDA receptors and positive modulation of a5 GABA A receptors: No changes in depressive-like behavior, while the former slightly increased emotional reactivity in unstressed rats
    Djordje J. Djorovic, Jana Ivanović, Kristina Jezdić, Dishary Sharmin, Jovana Aranđelović, James Minton Cook, Miroslav M. Savić · 2025 · Medicinska istrazivanja
  35. Transcranial direct current stimulation in the management of obsessive-compulsive disorder with comorbid bipolar affective disorder: A case study
    Mohita Joshi, Mansi Ranga, Sujita Kumar Kar · 2025 · Odisha Journal of Psychiatry
  36. Time to efficacious steady state plasma concentrations with slow titration of Vortioxetine drops versus oral tablets: a Pharmacokinetic model
    Andrea M. Fagiolini, Elin Heldbo Reines, Anja Farovik, Johan Areberg · 2025 · Annals of General Psychiatry
  37. Neurensin-2 is a negative regulator of CB1 receptor
    Yumna Abu Ghanem, Liora Dorfman-Yahad, Hadas Catane Hovav, Laila Agbariya, Adi Cohen, Hila Yehuda, Gali Umschweif · 2025 · Biochemical Pharmacology
  38. Ketamine for depression and other psychiatric diseases
    W. Roth · 2025 · Elsevier eBooks
  39. Antidepressant‐Like Effect of an Immediate‐Release Formulation of Mallotus oppositifolius in Mice
    Zakaria Abdullah Ibrahim, Ofosua Adi‐Dako, Kevin Kofi Adutwum-Ofosu, Patrick Amoateng, Frimpong Appiah, Awo Efua Koomson, Donatus Wewura Adongo, Awo Afi Kwapong, Kennedy Kwami Edem Kukuia · 2025 · Scientifica
  40. GDF11/TGFBR1 activation is essential for the antidepressant-like effect of H₂S: Role of suppressing the hippocampal cascade of necroptosis-neuroinflammation-Kynurenine pathway disorder
    Xiang Chen, Bo Wang, Yu-Hui Tang, Yi-Li Yi, Wei Zou, Xiao-Qing Tang, San-Qiao Yang · 2026 · Physiology & Behavior
  41. Plant-Based Antidepressants: An Overview of Bioactive Compounds and Screening Strategies
    Rohit Gupta, Neelottama Kushwaha, Swatantra K.S. Kushwaha · 2026 · Journal of Drug Delivery and Therapeutics
  42. Escitalopram treatment for patients with major depressive disorder: decision trees for treatment algorithm
    Xuequan Zhu, Rou Zhong, Xu Chen, Lei Feng, Yuan Feng, Ling Zhang, Gang Wang · 2026 · Journal of Psychiatric Research
  43. Non-implantable neuromodulation therapies compared to conventional treatments for major depression
    Victor Fontenelle Bastos Lima, Valquiria Aparecida Silva, Rebeca Pelosof, Vanessa Malfatti, Eric Cretaz, Kallene Summer Moreira Vidal, André R. Brunoni, Vitor Breseghello Cavenaghi · 2026 · Expert Review of Clinical Pharmacology
  44. Implication du métabolisme de la sérotonine dans les cancers du sein triple négatifs et perspectives cliniques
    Alice Marques Pinheiro · 2019 · theses.fr (ABES)
  45. Neuropathic pain and depression : molecular alterations in the anterior cingulate cortex
    Muris Humo · 2019 · theses.fr (ABES)
  46. Résistance à l’Insuline du Système Sérotoninergique : Implication dans les Troubles de l’Humeur Comorbides au Diabete De Type 2
    Hugo Martin · 2021 · theses.fr (ABES)
  47. Caractérisation neuro-computationnelle des troubles de la motivation dans la dépression : vers une médecine personnalisée en psychiatrie
    Claire Jaffré · 2023 · theses.fr (ABES)
  48. Caractérisation neuro-computationnelle de l'humeur : causes et conséquences
    Pablo Carrillo · 2024 · theses.fr (ABES)
  49. Fonction et régulation des gènes Dlx5/6 dans les neurones GABAergiques corticaux : Implications pour le comportement et pour le mécanisme d'action des antidépresseurs
    Rym Aouci · 2024 · theses.fr (ABES)
  50. Exploring the molecular determinants of behavioral changes induced by ketamine at the nanoscale
    Floriane Uyttersprot · 2024
  51. Contribution of the amygdalo-cingulate pathway in depression and its comorbidity with chronic pain
    Léa J. Becker · 2021
  52. Assessing logistical and ethical barriers for psychedelic-assisted therapy implementation: A cross-sectional pharmacist survey
    Sophia M. Castillo, Noelle Cataldo, Cody J. Wenthur · 2026 · Psychedelics
  53. Comparing the temporal pattern of symptom change across multiple treatments for depression
    Kobe Trauwaen, Kaat Hebbrecht, Jacqueline G. L. A-Tjak, Rob Kok, Miklós Árgyelán, Nic J.A. van der Wee, Nexhmedin Morina B, Noelle Arcaro, Kristof Vansteelandt, Pascal A. Sienaert et al. · 2026 · Journal of Affective Disorders
  54. Discovery of novel Kir4.1 inhibitors based on serdemetan with potential therapy for glioblastoma-depression comorbidity
    Hao Gu, Sisi Wang, Mengdan Li, Yunpeng Guo, Xuan Li, Zhaobing Gao, Jian Li, Hanfang Liu, Xiaoyu Zhou, Yixiang Xu · 2026 · Pharmaceutical Science Advances
  55. Ketamine and Evolving Neuroplasticity
    Angel Prabakar · 2026 · Clinical Drug Investigation
  56. The application of esketamine in cancer-related depressive states: attention from mechanisms to clinical translation
    Liangju Chen, Yonghua Chen, Ying Zhao, Tingting Feng, Xiaoyu Song, Fangmei Xie, Jian Shen, Jinhua He, Jinquan Guo, Lin Zhong · 2026 · Frontiers in Psychiatry
  57. Suicide and Depression
    Tae Hui Kim, Beomwoo Nam · 2026 · Springer eBooks
  58. Novel Antidepressants
    Jung Goo Lee, Young-Min Park · 2026 · Springer eBooks
  59. Clinical considerations for ethical SSRI prescribing in corrections
    W. R. Dennis, J. K. Young, M. S. Caldwell · 2026 · Criminal Justice Ethics
  60. Acute Antidepressant-Like Effects and Biphasic Dose–Response Profiles of Melissa officinalis and Nepeta menthoides in Mice
    Fatemeh Abbaszadeh, Masoumeh Jorjani, Mohsen Naseri, Sedighe Talebi · 2026 · Biomedicine Advances
  61. Profiling zuranolone as a treatment option for postpartum depression
    Christina Gonzalez‐Torres, Verinder Sharma · 2026 · Expert Review of Neurotherapeutics
  62. Differential-Reinforcement-of-Low-Rate (DRL) Operant Behavior: Methodological Issues and Effectiveness as an Antidepressant Assay
    Joseph H. Porter, Fan Zhang, Holly Covington, Todd M. Hillhouse · 2026 · Neuromethods
  63. Efficacy of Non-Invasive Brain Stimulation on the Treatment of Late Life Depression: A Systematic Review and Network Meta-Analysis.
    Che-Min Lin, Wen-Yin Chen, Yu-Tsung Liu, Huang-Li Lin, Shwu-Hua Lee, Chen-Hsin Yu, Chih-Chiang Chiu, Chi-Ming Chiang, Pei-Tsen Chen, Ying-Chih Cheng · 2026 · Acta Psychiatrica Scandinavica